Loading...
Immunotherapies Targeting α-Synuclein in Parkinson Disease
BACKGROUND: Parkinson disease (PD) is a progressive neurodegenerative disorder. Pathologic diagnosis of PD relies on loss of dopamine neurons in the substantia nigra and accumulation of the abnormal protein α-synuclein in the form of Lewy bodies and Lewy neurites. Alteration in aggregation propertie...
Na minha lista:
| Udgivet i: | Fed Pract |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontline Medical Communications Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7473734/ https://ncbi.nlm.nih.gov/pubmed/32908345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12788/fp.0026 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|